AR038208A1 - Composicion farmaceutica dispersable oralmente de mitiglinida - Google Patents
Composicion farmaceutica dispersable oralmente de mitiglinidaInfo
- Publication number
- AR038208A1 AR038208A1 ARP030100179A ARP030100179A AR038208A1 AR 038208 A1 AR038208 A1 AR 038208A1 AR P030100179 A ARP030100179 A AR P030100179A AR P030100179 A ARP030100179 A AR P030100179A AR 038208 A1 AR038208 A1 AR 038208A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- ortially
- mitiglinida
- dispersable
- mitiglinide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Composición farmacéutica sólida dispersable oralmente de mitiglinida que contiene mitiglinida o una de sus sales farmacéuticamente aceptables, y gránulos que consisten en lactosa y almidón cosecados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0200794A FR2834892B1 (fr) | 2002-01-23 | 2002-01-23 | Composition pharmaceutique orodispersible de mitiglinide |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038208A1 true AR038208A1 (es) | 2005-01-05 |
Family
ID=27589558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100179A AR038208A1 (es) | 2002-01-23 | 2003-01-22 | Composicion farmaceutica dispersable oralmente de mitiglinida |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR038208A1 (es) |
FR (1) | FR2834892B1 (es) |
WO (1) | WO2003061650A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050215607A1 (en) * | 2002-06-28 | 2005-09-29 | Imao Mikoshiba | Drug composition for prevention or inhibition of advance of diabetic complication |
CA2658549A1 (en) * | 2006-08-08 | 2008-02-14 | Kissei Pharmaceutical Co., Ltd. | Oral disintegrating tablet having masked bitter taste and method for production thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3506276C1 (de) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
PH31467A (en) * | 1994-01-31 | 1998-11-03 | Yamanouchi Pharma Co Ltd | Intrabucally dissolving compressed mouldings and production process thereof. |
FR2765578B1 (fr) * | 1997-07-03 | 1999-09-10 | Adir | Procede de preparation d'un perhydroisoindole substitue |
DE60036205T2 (de) * | 2000-07-27 | 2008-05-21 | Roquette Frères | Granulat bestehend aus Stärke und Laktose |
-
2002
- 2002-01-23 FR FR0200794A patent/FR2834892B1/fr not_active Expired - Fee Related
-
2003
- 2003-01-22 WO PCT/FR2003/000196 patent/WO2003061650A1/fr not_active Application Discontinuation
- 2003-01-22 AR ARP030100179A patent/AR038208A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
FR2834892A1 (fr) | 2003-07-25 |
WO2003061650A1 (fr) | 2003-07-31 |
FR2834892B1 (fr) | 2004-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR038207A1 (es) | Composicion farmaceutica dispersable oralmente de agomelatina | |
NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
NO20045434L (no) | En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom | |
ZA200501677B (en) | Hydantoin derivatives and their use as TACE inhibitors. | |
EP1587474A3 (en) | Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses | |
CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
LU92513I2 (fr) | Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi) | |
NO20052469D0 (no) | Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2. | |
NO20042635L (no) | 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin | |
NO20053356D0 (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
IL152916A0 (en) | Heteroaryl-phenyl heterobicyclic factor xa inhibitors | |
NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
NO20024528L (no) | Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen | |
DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
AR038305A1 (es) | Composicion farmaceutica dispersable oralmente de perindopril | |
AR038206A1 (es) | Composicion farmaceutica dispersable oralmente de ivabradina | |
AU2003224747A1 (en) | Technetium-labeled rotenone derivatives, and methods of use thereof | |
WO2005007137A8 (de) | Ambroxolhaltige tabletten | |
NO2010004I1 (no) | 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon | |
AR033467A1 (es) | Comprimido de meloxicam de rapida disgregacion | |
DK1202996T3 (da) | Titanforbindelser, fremstilling og anvendelse heraf | |
DK1523473T3 (da) | Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel. | |
NO20021007L (no) | Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-oner og deres anvendelse som lipasehemmere | |
EE05384B1 (et) | LaiaspektrilisedÁ2-(asendatudÁamino)bensoksasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁkasutamine,ÁfarmatseutilineÁkompositsioonÁjaÁmeetodÁretroviiruseÁreplikatsiooniÁinhibeerimiseks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |